Literature DB >> 10486391

Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography.

T Postert1, B Lack, W Kuhn, M Jergas, J Andrich, B Braun, H Przuntek, R Sprengelmeyer, M Agelink, T Büttner.   

Abstract

OBJECTIVES AND METHODS: Transcranial real time sonography (TCS) was applied to 49 patients with Huntington's disease and 39 control subjects to visualise alterations in the echotexture of the basal ganglia. For comparison T1 weighted, T2 weighted, and fast spin echo MRI was performed in 12 patients with Huntington's disease with and in nine patients without alterations of the basal ganglia echotexture as detected by TCS and T1 weighted, T2 weighted, and fast spin echo MRI. Furthermore, the widths of the frontal horns, third ventricle, and the lateral ventricles were depicted in TCS examinations and correlations examined with corresponding CT slices.
RESULTS: Eighteen out of 45 (40%) of the patients with Huntington's disease with adequate insonation conditions showed hyperechogenic lesions of at least one basal ganglia region. In 12 patients TCS depicted hyperechogenic lesions of the substantia nigra; in six patients the head of the caudate nucleus was affected. The lentiform nucleus (n=3) and the thalamus (n=0) were less often affected or spared. Hyperechogenic lesions were significantly more frequent in patients with Huntington's disease than in 39 control subjects, who had alterations of the echotexture in 12.8% (4/39) of the examinations. The number of CAG repeats and the clinical status correlated with the identification of hyperechogenic lesions of the substantia nigra (p<0.01). Hyperechogenic lesions of the caudate nucleus were associated with an increased signal intensity in T2 weighted MR images (p<0.05). All TCS parameters indicating brain atrophy correlated with CT findings (p<0.0001).
CONCLUSIONS: TCS detects primarily abnormalities of the caudate nucleus and substantia nigra in Huntington's disease. These changes in the echotexture may represent degenerative changes in the basal ganglia matrix and are partially associated with CAG repeat expansion and the severity of clinical findings.

Entities:  

Mesh:

Year:  1999        PMID: 10486391      PMCID: PMC1736595          DOI: 10.1136/jnnp.67.4.457

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life.

Authors:  L Angelini; N Nardocci; V Rumi; C Zorzi; L Strada; M Savoiardo
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

2.  Transcranial color-coded real-time sonography in adults.

Authors:  U Bogdahn; G Becker; J Winkler; K Greiner; J Perez; B Meurers
Journal:  Stroke       Date:  1990-12       Impact factor: 7.914

3.  Power Doppler compared to color-coded duplex sonography in the assessment of the basal cerebral circulation.

Authors:  T Postert; S Meves; C Börnke; H Przuntek; T Büttner
Journal:  J Neuroimaging       Date:  1997-10       Impact factor: 2.486

4.  Clinical and neuropathologic assessment of severity in Huntington's disease.

Authors:  R H Myers; J P Vonsattel; T J Stevens; L A Cupples; E P Richardson; J B Martin; E D Bird
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

5.  Neuropathology of Huntington's chorea. Studies of the ventrobasal complex of the thalamus.

Authors:  R Dom; M Malfroid; F Baro
Journal:  Neurology       Date:  1976-01       Impact factor: 9.910

6.  Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter.

Authors:  S T Grafton; S M Sumi; G K Stimac; E C Alvord; C M Shaw; D Nochlin
Journal:  Arch Neurol       Date:  1991-03

7.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.

Authors:  S E Andrew; Y P Goldberg; B Kremer; H Telenius; J Theilmann; S Adam; E Starr; F Squitieri; B Lin; M A Kalchman
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

8.  Clinical and magnetic resonance features of the classic and akinetic-rigid variants of Huntington's disease.

Authors:  D Oliva; F Carella; M Savoiardo; L Strada; P Giovannini; D Testa; G Filippini; T Caraceni; F Girotti
Journal:  Arch Neurol       Date:  1993-01

9.  Transcranial color-coded duplex sonography of intracerebral hematomas in adults.

Authors:  G Seidel; M Kaps; W Dorndorf
Journal:  Stroke       Date:  1993-10       Impact factor: 7.914

10.  Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.

Authors:  S M de la Monte; J P Vonsattel; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1988-09       Impact factor: 3.685

View more
  14 in total

Review 1.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

2.  An unusual gait disorder at the Emergency Department: role of the quantitative assessment of parenchymal transcranial Doppler sonography.

Authors:  Massimiliano Godani; Giuseppe Lanza; Lucia Trevisan; Raffaele Ferri; Rita Bella
Journal:  Quant Imaging Med Surg       Date:  2021-05

Review 3.  Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2010-09-10       Impact factor: 3.575

4.  Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography.

Authors:  Christos Krogias; Katrin Strassburger; Jens Eyding; Ralf Gold; Christine Norra; Georg Juckel; Carsten Saft; Dietmar Ninphius
Journal:  J Psychiatry Neurosci       Date:  2011-05       Impact factor: 6.186

Review 5.  [Sonography of the parenchyma in Parkinson's disease].

Authors:  J Hagenah; G Seidel
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

6.  Echogenicity of basal ganglia structures in different Huntington's disease phenotypes.

Authors:  Carsten Saft; Rainer Hoffmann; Katrin Strassburger-Krogias; Thomas Lücke; Saskia H Meves; Gisa Ellrichmann; Christos Krogias
Journal:  J Neural Transm (Vienna)       Date:  2014-12-13       Impact factor: 3.575

7.  Transcranial sonography for diagnosis of Parkinson's disease.

Authors:  Sabine Mehnert; Iris Reuter; Karsten Schepp; Peter Maaser; Erwin Stolz; Manfred Kaps
Journal:  BMC Neurol       Date:  2010-01-21       Impact factor: 2.474

Review 8.  Transcranial duplex in the differential diagnosis of parkinsonian syndromes: a systematic review.

Authors:  Annemarie M M Vlaar; Angela Bouwmans; Werner H Mess; Selma C Tromp; Wim E J Weber
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

9.  Motor behavior in rats after separate and combined administration of GABAergic agents into the neostriatum.

Authors:  V M Varshavskaya; O N Ivanova; A F Yakimovskii
Journal:  Neurosci Behav Physiol       Date:  2004-03

10.  Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV.

Authors:  Mark Obermann; M Küper; O Kastrup; O Yaldizli; S Esser; J Thiermann; E Koutsilieri; G Arendt; H-C Diener; M Maschke
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.